These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy. Lewis SJ; Kays MB; Mueller BA J Clin Pharmacol; 2016 Oct; 56(10):1277-87. PubMed ID: 26919659 [TBL] [Abstract][Full Text] [Related]
4. Removal of doripenem during hemodialysis and the optimum dosing regimen for patients undergoing hemodialysis. Tanoue K; Nishi K; Kadowaki D; Hirata S Ther Apher Dial; 2011 Jun; 15(3):327-33. PubMed ID: 21624085 [TBL] [Abstract][Full Text] [Related]
5. Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age. Cirillo I; Vaccaro N; Castaneda-Ruiz B; Redman R; Cossey V; Bradley JS; Allegaert K Antimicrob Agents Chemother; 2015 Aug; 59(8):4742-9. PubMed ID: 26014957 [TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections. Lee DH; Kim YK; Jin K; Kang MJ; Joo YD; Kim YW; Moon YS; Shin JG; Kiem S Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223378 [TBL] [Abstract][Full Text] [Related]
7. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration. Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665 [TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit. Abdul-Aziz MH; Abd Rahman AN; Mat-Nor MB; Sulaiman H; Wallis SC; Lipman J; Roberts JA; Staatz CE Antimicrob Agents Chemother; 2016 Jan; 60(1):206-14. PubMed ID: 26482304 [TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics and Pharmacodynamics of Doripenem in Obese, Hospitalized Patients. Chung EK; Fleming MR; Cheatham SC; Kays MB Ann Pharmacother; 2017 Mar; 51(3):209-218. PubMed ID: 28168884 [TBL] [Abstract][Full Text] [Related]
10. The doripenem serum concentrations in intensive care patients suffering from acute kidney injury, sepsis, and multi organ dysfunction syndrome undergoing continuous renal replacement therapy slow low-efficiency dialysis. Wieczorek A; Tokarz A; Gaszynski W; Gaszynski T Drug Des Devel Ther; 2014; 8():2039-44. PubMed ID: 25364230 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis. Cirillo I; Vaccaro N; Redman R; Black PL; Kearns GL J Clin Pharmacol; 2012 Nov; 52(11):1645-53. PubMed ID: 22174436 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumonia. Harada M; Inui N; Suda T; Nakamura Y; Wajima T; Matsuo Y; Chida K Int J Antimicrob Agents; 2013 Aug; 42(2):149-54. PubMed ID: 23684002 [TBL] [Abstract][Full Text] [Related]
13. [Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory]. Sumitani Y; Kobayashi Y Jpn J Antibiot; 2007 Dec; 60(6):394-403. PubMed ID: 18447209 [TBL] [Abstract][Full Text] [Related]
14. When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents. Goff DA; Nicolau DP Clin Ther; 2013 Jun; 35(6):766-71. PubMed ID: 23795574 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairment. Matsuo Y; Ishibashi T; Kubota R; Wajima T J Infect Chemother; 2015 Feb; 21(2):123-9. PubMed ID: 25487084 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of doripenem in infected patients treated within and outside the intensive care unit. Bhalodi AA; Keel RA; Quintiliani R; Lodise TP; Nicolau DP; Kuti JL Ann Pharmacother; 2013 May; 47(5):617-27. PubMed ID: 23585647 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia. Stein GE; Kulhanek G; Smith CL; Kuti JL; Nicolau DP; Scharmen A; Farnum C; Tran M; Kalra A; Havlichek DH Ann Pharmacother; 2012 Oct; 46(10):1281-6. PubMed ID: 23012385 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis. Rahbar AJ; Lodise TP; Abraham P; Lockwood A; Pai MP; Patka J; Rabinovich M; Curzio K; Chester K; Williams B; Morse B; Chaar M; Huang V; Salomone J Surg Infect (Larchmt); 2016 Dec; 17(6):675-682. PubMed ID: 27841954 [TBL] [Abstract][Full Text] [Related]
20. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility. Roberts JA; Lipman J Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]